88IV - PR Newswire Asia's news - Biotechnology

< Previous page

| Title only | Print

Next page >

2024ASCO｜Memorial Sloan Kettering Cancer Center (MSK)'s Prof. Wungki Park Unveils Precision Targeting of TF in Pancreatic Cancer, Signaling ADC Drug Innovations Introduction: ADC Drug Breakthrough Targets TF in Pancreatic Cancer ... 2024-06-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Innovent to Present Multiple Clinical Study Results of Mazdutide at the ADA's 84th Scientific Sessions SAN FRANCISCO and SUZHOU, China , June 12, 2024 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures ... 2024-06-12T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Biosion Today Presented Key Phase 2 POC Clinical Study Results for Bosakitug, an Anti-TSLP mAb, in Atopic Dermatitis Subjects at the Revolutionizing Atopic Dermatitis Conference NEWARK, Del. and NANJING , China , June 11, 2024 /PRNewswire/ -- Biosion, a global, clinical-stage biotechnology company, today presented key results from the ADAMANT study, a phase 2 proof-of-concept ... 2024-06-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
111, Inc., Scrianen Announce Strategic Direct Supply Partnership to Expand Nationwide Reach and Improve Drug Accessibility SHANGHAI , June 11, 2024 /PRNewswire/ -- 111, Inc. ("111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company committed to reshaping the value chain ... 2024-06-11T Banking/Financial Service Biotechnology Computer/Electronics Electronic Commerce
Global Registrational Phase III Study of Olverembatinib for the Treatment of Patients with SDH-Deficient GIST Approved by the China CDE SUZHOU, China , and ROCKVILLE, Md. , June 11, 2024 /PRNewswire/ -- Ascentage Pharma (6855.HK), a global biopharmaceutical company engaged in developing novel therapies for cancer, chronic hepatitis ... 2024-06-11T Banking/Financial Service Biotechnology Computer/Electronics Health Care/Hospital
Gannex Announces Poster Presentation of Positive Interim 12-Week Results from Phase II Clinical Trial of ASC41 in Patients with Biopsy-Confirmed MASH at EASL CONGRESS 2024 Up to 68.2% mean relative reduction in liver fat content from baseline among biopsy-confirmed metabolic dysfunction-associated steatohepatitis (MASH) patients receiving 12-week treatment of ASC41 ... 2024-06-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Full-Life Technologies Disclosed Preclinical Data of its NTSR1-targeting RDC Program FL-091 in an Oral Presentation at the 2024 SNMMI Annual Meeting SHANGHAI and HEIDELBERG , Germany , June 11, 2024 /PRNewswire/ -- Full-Life Technologies (Full-Life), a fully integrated global radiotherapeutics company, released preclinical data of its ... 2024-06-11T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
Kangpu Biopharmaceuticals to Present Results from Phase 2a of KPG-818 in SLE at EULAR 2024 HEFEI, China , June 10, 2024 /PRNewswire/ -- Kangpu Biopharmaceuticals today announced that a poster tour presentation highlighting the Phase 2a clinical data of KPG-818 in patients with Systemic ... 2024-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
FDA Grants Fast Track Designation to GCBP and Novel Pharma's GC1130A FDA's Fast Track designation speeds up the development of new biologic drugs for rare diseases YONGIN, South Korea , June 10, 2024 /PRNewswire/ -- GC Biopharma (006280. KS) and Novel Pharma ... 2024-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals
India Breakthrough: Bio Regenerative Precision Medicine Seminar Held in Hyderabad HYDERABAD, India , June 10, 2024 /PRNewswire/ -- The Bio Regenerative Precision Medicine Seminar, held from May 18-20, 2024 , at Le Méridien in Hyderabad , was a watershed moment in India's ... 2024-06-10T Biotechnology Health Care/Hospital Medical/Pharmaceuticals

< Previous page

Next page >

88iv | Home | Login

Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer

Copyright (C) 2024

Suntek Computer Systems Limited.

All rights reserved